Article
Formulation Fight: Amgen Case Tests Patentability Of Biopharmaceuticals In India
In a high-stakes case, the Madras High Court examines whether Amgen's specific formulation is non-obvious and patentable, and whether the prior art guides a skilled person to the invention.
Obhan & Associates